Related Experiment Videos
Quantitative high-performance liquid-chromatographic method for determining disopyramide (Norpace) in serum
Clinical Toxicology
|January 1, 1979
Summary
A new high-performance liquid-chromatographic method accurately measures disopyramide in serum. This validated assay offers high sensitivity and precision for clinical and research applications.
Area of Science:
- Analytical Chemistry
- Clinical Chemistry
- Pharmacokinetics
Background:
- Disopyramide is an antiarrhythmic drug requiring therapeutic drug monitoring.
- Accurate quantification of disopyramide in biological matrices is crucial for patient management.
Purpose of the Study:
- To develop and validate a sensitive and specific high-performance liquid-chromatographic (HPLC) method for disopyramide serum measurement.
Main Methods:
- Serum samples (0.5 ml) were extracted with chloroform containing p-chlorodisopyramide as an internal standard.
- Separation was performed on a reversed-phase octadecylsilyl column at room temperature.
- Detection was achieved at 254 nm.
Main Results:
- The method demonstrated sensitivity down to 0.2 mg/L with linearity up to 10 mg/L.
- Within-day and day-to-day precision (CV) were below 10% at various concentrations.
- Average recovery was 98%, with minimal interference from over 85 other drugs.
Conclusions:
- This HPLC method provides a reliable, sensitive, and specific means for quantifying disopyramide in serum.
- The assay is suitable for routine clinical laboratory use and pharmacokinetic studies.